Cost effectiveness analysis of the USE of antibiotics ceftriaxone and levofloxacin in bpjs patients urinary tract infection (UTI) hospitalization at RSM ahmad dahlan kediri city year 2022
Abstract
Numerous health interventions with varying degrees of success are evaluated using cost-effectiveness analysis in pharmacoeconomic research. When bacteria and other infectious microbes make their way up the urinary canal from the urethra and multiply in the bladder, it may lead to infections in the kidneys and ureters. It is estimated that gram-negative bacteria, especially Escherichia coli, are responsible for almost 90% of UTIs. Anyone, from youth to the elderly, is susceptible to urinary tract infections, which disproportionately affect females. We want to learn more about the relative merits of ceftriaxone and levofloxacin in treating UTIs at Ahmad Dahlan Hospital by conducting this cost-effectiveness analysis. In this study, we used a descriptive technique and gathered data retrospectively. To determine the cost-effectiveness, we averaged the direct medical costs and compared the ACER and ICER values. At Ahmad Dahlan Hospital in Kediri City, the average direct medical expenditure for ceftriaxone medication for UTI patients was 3,150,180 Rp. in 2022. At the same time, the same group of patients at the same hospital had average direct medical expenditures of Rp. 2,901,338 for levofloxacin antibiotics. With an ACER value of Rp. 120,889,083, levofloxacin antibiotics are determined to be the most cost-effective..
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.